Odysight.ai Ends $20M ATM, Locks In Terms for $11M Underwritten Offering
ODYS sits 27% above its 52-week low of $2.6 on elevated volume (3.3× avg).
Summary
Odysight.ai terminated its $20M ATM and finalized terms for its $11M underwritten offering, with no shares sold under the ATM.
Key Events · Financing and Capital Events · ODYS
-
ATM Program Terminated
The $20M at-the-market sales agreement with Roth Capital Partners was terminated on August 20, 2026, with no shares sold under that program.
-
Underwritten Offering Finalized
Underwriting agreement for 3,437,500 shares at $3.20 per share, raising $11M gross, with a 30-day option for 515,625 additional shares.
-
Underwriting Costs
Roth Capital Partners receives a 6.5% underwriting discount and up to $75,000 in expense reimbursements.
-
Insider Lock-Up
Company and all directors and executive officers are subject to a 45-day lock-up period following the underwriting agreement.
Analysis · ODYS · Technology
The termination of Odysight.ai's $20 million at-the-market program with Roth Capital Partners and the finalization of the underwriting agreement for its $11 million firm commitment offering mark a shift from a flexible drip-feed facility to a one-time capital raise, with zero sales under the ATM. The 6.5% underwriting discount and 45-day insider lock-up are standard but confirm the deal's cost. Net proceeds fund R&D, sales, and working capital as the company works through a 79% H1 revenue decline and a $9.5M net loss.
How filings like this one have moved
In the 30 days to Aug 22, 2026, 29.1% of the 2927 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ODYS was trading at $3.31 on NASDAQ in the Technology sector, with a market capitalization of approximately $56.3M. The 52-week trading range was $2.60 to $11.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.